Taiwan Liposome Company, Ltd. (TLC) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Taipei, Taiwan. The current CEO is Keelung Hong.
TLC has IPO date of 2018-11-21, listed on the NASDAQ Global Market.
No company description available.
